TY - JOUR
T1 - Silver nanocomposites based on the bacterial fucose-rich polysaccharide secreted by Enterobacter A47 for wound dressing applications: Synthesis, characterization and in vitro bioactivity
AU - Concórdio-Reis, Patrícia
AU - Pereira, Carolina V.
AU - Batista, Miguel P.
AU - Sevrin, Chantal
AU - Grandfils, Christian
AU - Marques, Ana C.
AU - Fortunato, Elvira
AU - Gaspar, Frédéric B.
AU - Matias, Ana A.
AU - Freitas, Filomena
AU - Reis, Maria A. M.
N1 - info:eu-repo/grantAgreement/FCT/5876/147333/PT#
This work was supported by the Applied Molecular Biosciences Unit-UCIBIO, the Materials Research Center, CENIMAT/i3N iNOVA4 and the Health Research Unit which are financed by national funds from Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia e do Ensino Superior, FCT/MCTES (UID/Multi/04378/2019, LISBOA-01-0145-FEDER-007344, respectively) and by co-financed by the ERDF, under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728).
PCR and ACM acknowledge funding from FCT/MCTES, through the PhD Grants SFRH/BD/131947/2017 and SFRH/BD/115173/2016, respectively.
PY - 2020/11/15
Y1 - 2020/11/15
N2 - This study demonstrates the potential of a high molecular weight fucose-containing polysaccharide secreted by the bacterium Enterobacter A47, named FucoPol, and its silver nanocomposite as potential bioactive materials for wound dressings applications. A green, simple, light-assisted method was used for the synthesis of silver nanoparticles (AgNP) using FucoPol, as stabilizing and reducing agent. The synthesized nanoparticles were spherical, and the main population had a particle size in number ranging between 13 and 30 nm for percentiles 50 and 90, respectively. FucoPol, as well as the functionalized material, besides having no cytotoxicity towards human skin keratinocytes and mouse fibroblasts, also promoted in vitro keratinocytes migration. These observations not only show the safety of FucoPol and FucoPol/AgNP biocomposite, but also their wound healing ability. Moreover, the biocomposite had a strong antimicrobial activity against Staphylococcus aureus ATCC 6538 and Klebsiella pneumoniae CECT 8453, two representative strains of known skin commensal pathogens. These findings demonstrate for the first time the potential of FucoPol for the development of wound healing formulations. Additionally, the FucoPol/AgNP biocomposite might find use in antimicrobial biomaterials, including antibacterial wound healing formulations, which further strengthens the establishment of FucoPol as a bioactive biopolymer.
AB - This study demonstrates the potential of a high molecular weight fucose-containing polysaccharide secreted by the bacterium Enterobacter A47, named FucoPol, and its silver nanocomposite as potential bioactive materials for wound dressings applications. A green, simple, light-assisted method was used for the synthesis of silver nanoparticles (AgNP) using FucoPol, as stabilizing and reducing agent. The synthesized nanoparticles were spherical, and the main population had a particle size in number ranging between 13 and 30 nm for percentiles 50 and 90, respectively. FucoPol, as well as the functionalized material, besides having no cytotoxicity towards human skin keratinocytes and mouse fibroblasts, also promoted in vitro keratinocytes migration. These observations not only show the safety of FucoPol and FucoPol/AgNP biocomposite, but also their wound healing ability. Moreover, the biocomposite had a strong antimicrobial activity against Staphylococcus aureus ATCC 6538 and Klebsiella pneumoniae CECT 8453, two representative strains of known skin commensal pathogens. These findings demonstrate for the first time the potential of FucoPol for the development of wound healing formulations. Additionally, the FucoPol/AgNP biocomposite might find use in antimicrobial biomaterials, including antibacterial wound healing formulations, which further strengthens the establishment of FucoPol as a bioactive biopolymer.
KW - Fucan
KW - Silver nanoparticles, AgNP
KW - Wound healing
UR - http://www.scopus.com/inward/record.url?scp=85087959970&partnerID=8YFLogxK
U2 - 10.1016/j.ijbiomac.2020.07.072
DO - 10.1016/j.ijbiomac.2020.07.072
M3 - Article
C2 - 32653376
AN - SCOPUS:85087959970
SN - 0141-8130
VL - 163
SP - 959
EP - 969
JO - International Journal of Biological Macromolecules
JF - International Journal of Biological Macromolecules
ER -